Polymodal Transient Receptor Potential Vanilloid Type 1 Nocisensor: Structure, Modulators, and Therapeutic Applications

被引:38
|
作者
Cui, Minghua
Gosu, Vijayakumar
Basith, Shaherin
Hong, Sunhye
Choi, Sun [1 ]
机构
[1] Ewha Womans Univ, Natl Leading Res Lab Mol Modeling & Drug Design N, Coll Pharm, Seoul, South Korea
关键词
ROOT GANGLION NEURONS; TRPV1; ION-CHANNEL; ANTAGONIST-INDUCED HYPERTHERMIA; CAPSAICIN-ACTIVATED CURRENTS; C-REGION ANALOGS; 3-PHASE; TRIALS; PAIN RELIEF; BODY-TEMPERATURE; VR1; RECEPTORS; IN-VIVO;
D O I
10.1016/bs.apcsb.2015.11.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transient receptor potential (TRP) channels belong to a superfamily of sensory-related ion channels responding to a wide variety of thermal, mechanical, or chemical stimuli. In an attempt to comprehend the piquancy and pain mechanism of the archetypal vanilloids, transient receptor potential vanilloid (TRPV) 1 was discovered. TRPV1, a well-established member of the TRP family, is implicated in a range of functions including inflammation, painful stimuli sensation, and mechanotransduction. TRPV1 channels are nonselective cation receptors that are gated by a broad array of noxious ligands. Such polymodal-sensor aspect makes the TRPV1 channel extremely versatile and important for its role in sensing burning pain. Besides ligands, TRPV1 signaling can also be modulated by lipids, secondary messengers, protein kinases, cytoskeleton, and several other proteins. Due to its central role in hyperalgesia transduction and inflammatory processes, it is considered as the primary pharmacological pain target. Moreover, understanding the structural and functional intricacies of the channel is indispensable for the therapeutic intervention of TRPV1 in pain and other pathological disorders. In this chapter, we seek to give a mechanistic outlook on the TRPV1 channel. Specifically, we will explore the TRPV1 structure, activation, modulation, ligands, and its therapeutic targeting. However, the major objective of this review is to highlight the fact that TRPV1 channel can be treated as an effective therapeutic target for treating several pain-and nonpain-related physiological and pathological states.
引用
收藏
页码:81 / 125
页数:45
相关论文
共 50 条
  • [1] The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain
    Westaway, Susan M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (11) : 2589 - 2596
  • [2] The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor
    Holzer, P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 155 (08) : 1145 - 1162
  • [3] A patent review of transient receptor potential vanilloid type 1 modulators (2014-present)
    Gao, Mengkang
    Wang, Yusui
    Liu, Lanqi
    Qiao, Zhenrui
    Yan, Lin
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2021, 31 (02) : 169 - 187
  • [4] Transient receptor potential vanilloid 1 as a therapeutic target in analgesia
    Szolcsanyi, Janos
    Pinter, Erika
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (06) : 641 - 657
  • [5] Polymodal Transient Receptor Potential Vanilloid (TRPV) Ion Channels in Chondrogenic Cells
    Somogyi, Csilla Szucs
    Matta, Csaba
    Foldvari, Zsofia
    Juhasz, Tamas
    Katona, Eva
    Takacs, Adam Roland
    Hajdu, Tibor
    Dobrosi, Nora
    Gergely, Pal
    Zakany, Roza
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (08) : 18412 - 18438
  • [6] Furanocoumarins Are a Novel Class of Modulators for the Transient Receptor Potential Vanilloid Type 1 (TRPV1) Channel*
    Chen, Xingjuan
    Sun, Weiyang
    Gianaris, Nicholas G.
    Riley, Ashley M.
    Cummins, Theodore R.
    Fehrenbacher, Jill C.
    Obukhov, Alexander G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (14) : 9600 - 9610
  • [7] Transient receptor potential vanilloid type 1 and pain development
    Palazzo, Enza
    Luongo, Livio
    de Novellis, Vito
    Rossi, Francesco
    Marabese, Ida
    Maione, Sabatino
    CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (01) : 9 - 17
  • [8] Transient receptor potential vanilloid subtype 1: A potential therapeutic target for fibrotic diseases
    Peng, Guangxin
    Tang, Xiaoling
    Gui, Yang
    Yang, Jing
    Ye, Lifang
    Wu, Liuyang
    Ding, Ya Hui
    Wang, Lihong
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [9] Transient receptor potential vanilloid type 1 receptors in hypertensive renal damage - A promising therapeutic target?
    Ditting, Tilmann
    Veelken, Roland
    Hilgers, Karl F.
    HYPERTENSION, 2008, 52 (02) : 213 - 214
  • [10] Molecular Structure of Transient Receptor Potential Vanilloid Type 1 Ion Channel (TRPV1)
    Urban, Laszlo
    White, John P. M.
    Nagy, Istvan
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (01) : 115 - 121